摘要
The regrowth of residual tumor left by incomplete surgery leads to bladder cancer recurrence. Postoperative intravesical instillation in clinic shows unsatisfactory recurrence inhibition owing to rapid drug emptying and non-specific distribution. Here, inspired by intrinsic bacterial adhesion towards exposed wounds through fibronectin binding peptide, we develop a bacteria-inspired peptide-based nanoparticle that tar-gets exposed fibronectin on the surgical bed with residual tumor. Upon binding, the nanoparticle si-multaneously transforms into fibrous coating as drug depots for long-term release of encapsulated doxorubicin. The transformable nanoparticle retains 8.5-fold higher doxorubicin concentration than free one in bladders of live mice 3 days post-instillation. Reasonably, this formulation obviously suppresses tumor regrowth in an incomplete tumor resection model. Compared to the clinical doxorubicin treatment, it reduces the recurrence rate from 71% to 29% in a murine orthotopic bladder cancer model. This bacteria -inspired biomaterial provides a promising intravesical treatment but also opportunities for clinical man-agement on cancer recurrence.
-
单位哈尔滨医科大学; 郑州大学; 中国科学院; 国家纳米科学中心; 中国科学院研究生院; 北京科技大学